Monopar Therapeutics (MNPR) stock
MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$71.06−0.91 (-1.26%)
Close on Nov 17, 2026Market cap $476.97MP/E –Yield –
Monopar Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Monopar Therapeutics's price to book ratio was 3.7× on Nov 11, 2026, against 4.1× a year earlier. Over the last 5 years it ranged from 0.6× to 31.3×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.7× | +0.6 |
| 2025 | Dec 31, 2025 | 3.1× | −12.6 |
| 2024 | Dec 31, 2024 | 15.7× | +14.9 |
| 2023 | Dec 29, 2023 | 0.7× | −1.7 |
| 2022 | Dec 30, 2022 | 2.4× | +0.5 |
| 2021 | Dec 31, 2021 | 1.9× | −2.1 |
| 2020 | Dec 31, 2020 | 4.0× | −29.3 |
| 2019 | Dec 31, 2019 | 33.3× | – |
See a number that looks wrong?